Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mauri

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Pharmacopsychiatry|June 2, 2007
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levelsM C Mauri, A Colasanti, M Rossattini, et al.
Acta Haematologica|January 1, 1989
Increasing interdependency of prognosis- and therapy-related factors in Hodgkin's diseaseP G Gobbi, C Cavalli, M Federico, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 12, 2005
Clinical outcome and olanzapine plasma levels in acute schizophreniaM C Mauri, C P C Steinhilber, R Marino, et al.
Haemostasis|January 1, 1987
Severe platelet dysfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIaC L Balduini, G Grignani, F Sinigaglia, et al.
Human Psychopharmacology|July 15, 2003
Long-term efficacy and therapeutic drug monitoring of sertraline in major depressionMassimo C Mauri, Alessio Fiorentini, Giancarlo Cerveri, et al.
Lancet (London, England)|March 26, 1988
Hodgkin's disease prognosis: a directly predictive equationP G Gobbi, C Cavalli, M Federico, et al.
Arthritis and Rheumatism|March 23, 2000
A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritisL Marinova-Mutafchieva, R O Williams, C Mauri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipramS E Ross, R O Williams, L J Mason, et al.
Journal of Psychopharmacology (Oxford, England)|May 2, 2009
Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levelsL S Volonteri, A Colasanti, G Cerveri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2003
Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-upGiovanni M Ruggiero, Massimo C Mauri, Anna C Omboni, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Pharmacopsychiatry|June 2, 2007
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levelsM C Mauri, A Colasanti, M Rossattini, et al.
Acta Haematologica|January 1, 1989
Increasing interdependency of prognosis- and therapy-related factors in Hodgkin's diseaseP G Gobbi, C Cavalli, M Federico, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 12, 2005
Clinical outcome and olanzapine plasma levels in acute schizophreniaM C Mauri, C P C Steinhilber, R Marino, et al.
Haemostasis|January 1, 1987
Severe platelet dysfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIaC L Balduini, G Grignani, F Sinigaglia, et al.
Human Psychopharmacology|July 15, 2003
Long-term efficacy and therapeutic drug monitoring of sertraline in major depressionMassimo C Mauri, Alessio Fiorentini, Giancarlo Cerveri, et al.
Lancet (London, England)|March 26, 1988
Hodgkin's disease prognosis: a directly predictive equationP G Gobbi, C Cavalli, M Federico, et al.
Arthritis and Rheumatism|March 23, 2000
A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritisL Marinova-Mutafchieva, R O Williams, C Mauri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipramS E Ross, R O Williams, L J Mason, et al.
Journal of Psychopharmacology (Oxford, England)|May 2, 2009
Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levelsL S Volonteri, A Colasanti, G Cerveri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2003
Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-upGiovanni M Ruggiero, Massimo C Mauri, Anna C Omboni, et al.
Pageof 14